(Q38221608)

English

A systematic review and critical assessment of 11 discordant meta-analyses on reduced-function CYP2C19 genotype and risk of adverse clinical outcomes in clopidogrel users

scientific article published on 19 June 2014

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

31 August 2017

0 references

A systematic review and critical assessment of 11 discordant meta-analyses on reduced-function CYP2C19 genotype and risk of adverse clinical outcomes in clopidogrel users (English)

1 reference

Europe PubMed Central

PubMed publication ID

31 August 2017

0 references

1 reference

based on heuristic

inferred from title

systematic review

1 reference

based on heuristic

inferred from title

Cecile Janssens

7

object named as

A Cecile J W Janssens

1 reference

Europe PubMed Central

PubMed publication ID

31 August 2017

author name string

Ruben L Osnabrugge

1

1 reference

Europe PubMed Central

PubMed publication ID

31 August 2017

Stuart J Head

2

1 reference

Europe PubMed Central

PubMed publication ID

31 August 2017

Felix Zijlstra

3

1 reference

Europe PubMed Central

PubMed publication ID

31 August 2017

Jurriën M ten Berg

4

1 reference

Europe PubMed Central

PubMed publication ID

31 August 2017

Myriam G Hunink

5

1 reference

Europe PubMed Central

PubMed publication ID

31 August 2017

A Pieter Kappetein

6

1 reference

Europe PubMed Central

PubMed publication ID

31 August 2017

language of work or name

0 references

publication date

19 June 2014

1 reference

Europe PubMed Central

PubMed publication ID

31 August 2017

Genetics in Medicine

1 reference

Europe PubMed Central

PubMed publication ID

31 August 2017

17

1 reference

Europe PubMed Central

PubMed publication ID

31 August 2017

1

1 reference

Europe PubMed Central

PubMed publication ID

31 August 2017

3-11

1 reference

Europe PubMed Central

PubMed publication ID

31 August 2017

2013 ACCF/AHA guideline for the management of ST-elevation myocardial infarction: a report of the American College of Cardiology Foundation/American Heart Association Task Force on Practice Guidelines

1 reference

https://api.crossref.org/works/10.1038%2FGIM.2014.76

21 January 2018

Impact of CYP2C19 variant genotypes on clinical efficacy of antiplatelet treatment with clopidogrel: systematic review and meta-analysis

1 reference

https://api.crossref.org/works/10.1038%2FGIM.2014.76

21 January 2018

CYP2C19 genotype, clopidogrel metabolism, platelet function, and cardiovascular events: a systematic review and meta-analysis

1 reference

https://api.crossref.org/works/10.1038%2FGIM.2014.76

21 January 2018

Cardiovascular risk in clopidogrel-treated patients according to cytochrome P450 2C19*2 loss-of-function allele or proton pump inhibitor coadministration: a systematic meta-analysis

1 reference

https://api.crossref.org/works/10.1038%2FGIM.2014.76

21 January 2018

Reduced-function CYP2C19 genotype and risk of adverse clinical outcomes among patients treated with clopidogrel predominantly for PCI: a meta-analysis

1 reference

https://api.crossref.org/works/10.1038%2FGIM.2014.76

21 January 2018

Overlapping meta-analyses on the same topic: survey of published studies

1 reference

https://api.crossref.org/works/10.1038%2FGIM.2014.76

21 January 2018

Review and recommendations on the current practice of meta-analyses: a guide to appraise the evidence.

1 reference

https://api.crossref.org/works/10.1038%2FGIM.2014.76

21 January 2018

The PRISMA statement for reporting systematic reviews and meta-analyses of studies that evaluate health care interventions: explanation and elaboration

1 reference

https://api.crossref.org/works/10.1038%2FGIM.2014.76

21 January 2018

GRADE guidelines: 7. Rating the quality of evidence--inconsistency

1 reference

https://api.crossref.org/works/10.1038%2FGIM.2014.76

21 January 2018

GRADE guidelines: 5. Rating the quality of evidence--publication bias

1 reference

https://api.crossref.org/works/10.1038%2FGIM.2014.76

21 January 2018

Development of AMSTAR: a measurement tool to assess the methodological quality of systematic reviews

1 reference

https://api.crossref.org/works/10.1038%2FGIM.2014.76

21 January 2018

Measuring inconsistency in meta-analyses

1 reference

https://api.crossref.org/works/10.1038%2FGIM.2014.76

21 January 2018

The existence of publication bias and risk factors for its occurrence

1 reference

https://api.crossref.org/works/10.1038%2FGIM.2014.76

21 January 2018

Bias in meta-analysis detected by a simple, graphical test

1 reference

https://api.crossref.org/works/10.1038%2FGIM.2014.76

21 January 2018

A modified test for small-study effects in meta-analyses of controlled trials with binary endpoints

1 reference

https://api.crossref.org/works/10.1038%2FGIM.2014.76

21 January 2018

Systematic reviews in health care: Investigating and dealing with publication and other biases in meta-analysis

1 reference

https://api.crossref.org/works/10.1038%2FGIM.2014.76

21 January 2018

Clinical end points in coronary stent trials: a case for standardized definitions

1 reference

https://api.crossref.org/works/10.1038%2FGIM.2014.76

21 January 2018

Meta-analyses of the association between cytochrome CYP2C19 loss- and gain-of-function polymorphisms and cardiovascular outcomes in patients with coronary artery disease treated with clopidogrel

1 reference

https://api.crossref.org/works/10.1038%2FGIM.2014.76

21 January 2018

Meta-analysis of cytochrome P450 2C19 polymorphism and risk of adverse clinical outcomes among coronary artery disease patients of different ethnic groups treated with clopidogrel

1 reference

https://api.crossref.org/works/10.1038%2FGIM.2014.76

21 January 2018

CYP2C19*2/ABCB1-C3435T polymorphism and risk of cardiovascular events in coronary artery disease patients on clopidogrel: is clinical testing helpful?

1 reference

https://api.crossref.org/works/10.1038%2FGIM.2014.76

21 January 2018

Cytochrome P450 2C19*2 polymorphism and cardiovascular recurrences in patients taking clopidogrel: a meta-analysis

1 reference

https://api.crossref.org/works/10.1038%2FGIM.2014.76

21 January 2018

Effects of VerifyNow P2Y12 test and CYP2C19*2 testing on clinical outcomes of patients with cardiovascular disease: a systematic review and meta-analysis

1 reference

https://api.crossref.org/works/10.1038%2FGIM.2014.76

21 January 2018

Strengthening the Reporting of Observational Studies in Epidemiology (STROBE) statement: guidelines for reporting observational studies

1 reference

https://api.crossref.org/works/10.1038%2FGIM.2014.76

21 January 2018

STrengthening the REporting of Genetic Association studies (STREGA)--an extension of the STROBE statement

1 reference

https://api.crossref.org/works/10.1038%2FGIM.2014.76

21 January 2018

Variability in on-treatment platelet reactivity explained by CYP2C19*2 genotype is modest in clopidogrel pretreated patients undergoing coronary stenting.

1 reference

https://api.crossref.org/works/10.1038%2FGIM.2014.76

21 January 2018

Prospective evaluation of on-clopidogrel platelet reactivity over time in patients treated with percutaneous coronary intervention relationship with gene polymorphisms and clinical outcome.

1 reference

https://api.crossref.org/works/10.1038%2FGIM.2014.76

21 January 2018

Cytochrome P450 2C19 polymorphism, suboptimal reperfusion and all-cause mortality in patients with acute myocardial infarction

1 reference

https://api.crossref.org/works/10.1038%2FGIM.2014.76

21 January 2018

Effects of CYP2C19 genotype on outcomes of clopidogrel treatment

1 reference

https://api.crossref.org/works/10.1038%2FGIM.2014.76

21 January 2018

Protective effect of the CYP2C19 *17 polymorphism with increased activation of clopidogrel on cardiovascular events

1 reference

https://api.crossref.org/works/10.1038%2FGIM.2014.76

21 January 2018

Coexisting polymorphisms of P2Y12 and CYP2C19 genes as a risk factor for persistent platelet activation with clopidogrel.

1 reference

https://api.crossref.org/works/10.1038%2FGIM.2014.76

21 January 2018

Cytochrome P450 2C19 polymorphism in young patients treated with clopidogrel after myocardial infarction: a cohort study

1 reference

https://api.crossref.org/works/10.1038%2FGIM.2014.76

21 January 2018

Genetic determinants of response to clopidogrel and cardiovascular events

1 reference

https://api.crossref.org/works/10.1038%2FGIM.2014.76

21 January 2018

Bioequivalence revisited: influence of age and sex on CYP enzymes

1 reference

https://api.crossref.org/works/10.1038%2FGIM.2014.76

21 January 2018

Clopidogrel efficacy and cigarette smoking status.

1 reference

https://api.crossref.org/works/10.1038%2FGIM.2014.76

21 January 2018

The influence of smoking status on the pharmacokinetics and pharmacodynamics of clopidogrel and prasugrel: the PARADOX study.

1 reference

https://api.crossref.org/works/10.1038%2FGIM.2014.76

21 January 2018

Carriage of reduced-function CYP2C19 allele among patients treated with clopidogrel

1 reference

https://api.crossref.org/works/10.1038%2FGIM.2014.76

21 January 2018

Statistical heterogeneity in systematic reviews of clinical trials: a critical appraisal of guidelines and practice.

1 reference

https://api.crossref.org/works/10.1038%2FGIM.2014.76

21 January 2018

Quantifying heterogeneity in a meta-analysis

1 reference

https://api.crossref.org/works/10.1038%2FGIM.2014.76

21 January 2018

Assessment of cumulative evidence on genetic associations: interim guidelines

1 reference

https://api.crossref.org/works/10.1038%2FGIM.2014.76

21 January 2018

The problem of duplicate systematic reviews

1 reference

https://api.crossref.org/works/10.1038%2FGIM.2014.76

21 January 2018

Standard- vs high-dose clopidogrel based on platelet function testing after percutaneous coronary intervention: the GRAVITAS randomized trial

1 reference

https://api.crossref.org/works/10.1038%2FGIM.2014.76

21 January 2018

Point-of-care genetic testing for personalisation of antiplatelet treatment (RAPID GENE): a prospective, randomised, proof-of-concept trial

1 reference

https://api.crossref.org/works/10.1038%2FGIM.2014.76

21 January 2018

Association of genetic variants in CYP2C19 and adverse clinical outcomes after treatment with clopidogrel: an updated meta-analysis

1 reference

https://pubmed.ncbi.nlm.nih.gov/24946154

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

The existence of publication bias and risk factors for its occurrence

1 reference

https://pubmed.ncbi.nlm.nih.gov/24946154

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Impact of CYP2C19 polymorphism on residual platelet reactivity in patients with coronary heart disease during antiplatelet therapy

1 reference

https://pubmed.ncbi.nlm.nih.gov/24946154

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Bedside monitoring to adjust antiplatelet therapy for coronary stenting

1 reference

https://pubmed.ncbi.nlm.nih.gov/24946154

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Cytochrome P450 2C19 loss-of-function polymorphism is a major determinant of clopidogrel responsiveness in healthy subjects

1 reference

https://pubmed.ncbi.nlm.nih.gov/24946154

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Evidence based medicine

1 reference

https://pubmed.ncbi.nlm.nih.gov/24946154

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Platelet function during extended prasugrel and clopidogrel therapy for patients with ACS treated without revascularization: the TRILOGY ACS platelet function substudy

1 reference

https://pubmed.ncbi.nlm.nih.gov/24946154

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Effect of CYP2C19*2 and *3 loss-of-function alleles on platelet reactivity and adverse clinical events in East Asian acute myocardial infarction survivors treated with clopidogrel and aspirin

1 reference

https://pubmed.ncbi.nlm.nih.gov/24946154

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

A guide to interpreting discordant systematic reviews

1 reference

https://pubmed.ncbi.nlm.nih.gov/24946154

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Long-term clinical outcome after a first angiographically confirmed coronary stent thrombosis: an analysis of 431 cases

1 reference

https://pubmed.ncbi.nlm.nih.gov/24946154

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Cytochrome P450 2C19 polymorphism is associated with poor clinical outcomes in coronary artery disease patients treated with clopidogrel

1 reference

https://pubmed.ncbi.nlm.nih.gov/24946154

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Determination of cut-off levels for on-clopidogrel platelet aggregation based on functional CYP2C19 gene variants in patients undergoing elective percutaneous coronary intervention

1 reference

https://pubmed.ncbi.nlm.nih.gov/24946154

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Analysing Data and Undertaking Meta-Analyses

1 reference

https://api.crossref.org/works/10.1038%2FGIM.2014.76

7 January 2021

based on heuristic

inferred from DOI database lookup

Identifiers

10.1038/GIM.2014.76

1 reference

Europe PubMed Central

PubMed publication ID

31 August 2017

PubMed publication ID

1 reference

Europe PubMed Central

PubMed publication ID

31 August 2017

ResearchGate publication ID

0 references

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q38221608&oldid=2201429069"